Why You Can't Prescribe Under Your Collaborator's DEA Number

Can you prescribe on your collaborator's DEA number while yours is pending?

No, and the prohibition is criminal rather than administrative. Federal law makes it unlawful to knowingly or intentionally use, in the course of dispensing a controlled substance, a registration number issued to another person, and a first violation carries a term of imprisonment of not more than four years, a fine, or both 1Ref 1Office of the Law Revision Counsel, U.S. House of Representatives (2026).21 U.S.C. § 843 — Prohibited acts C.The federal prohibition at § 843(a)(2) on knowingly or intentionally using, in dispensing a controlled substance, a registration number issued to another person, that it is written against any person, and the § 843(d)(1) maximum of not more than four years' imprisonment, a fine, or both, rising to eight years after a prior conviction under the section.. A signed collaboration agreement changes none of that. The agreement is a state instrument; the registration is a federal one.

The rule that decides who may write the script sits in DEA's regulations rather than in the criminal statute. A controlled-substance prescription may be issued only by an individual practitioner who is authorized to prescribe by the jurisdiction in which licensed and who is either registered with DEA or exempted from registration under two named sections 2Ref 2Drug Enforcement Administration, Department of Justice (2024).§ 1306.03 Persons entitled to issue prescriptions..That a controlled-substance prescription may be issued only by an individual practitioner both authorized to prescribe by the jurisdiction in which licensed and either registered or exempted under a closed list of two named sections, which does not include the agent and employee exemption.. That list names two sections, 1301.22(c) and 1301.23, and neither of them describes a physician in private practice lending a number to a colleague.

The statute reaches further than whoever typed the prescription. Section 843(a)(2) is written against any person who knowingly uses another's registration number in dispensing a controlled substance 1Ref 1Office of the Law Revision Counsel, U.S. House of Representatives (2026).21 U.S.C. § 843 — Prohibited acts C.The federal prohibition at § 843(a)(2) on knowingly or intentionally using, in dispensing a controlled substance, a registration number issued to another person, that it is written against any person, and the § 843(d)(1) maximum of not more than four years' imprisonment, a fine, or both, rising to eight years after a prior conviction under the section.. What that wording means for the physician who supplied the number is a question for counsel, and not one the section settles on its face.

The two exemptions, and what each one covers

Two exemptions in section 1301.22 let a person work without a registration of their own, and neither reaches a nurse practitioner in a private collaborative practice. The first covers agents and employees, and its own text stops short of prescribing: it permits an exempt person, acting in the normal course of business or employment, to administer or dispense controlled substances other than by issuance of prescription 3Ref 3Drug Enforcement Administration, Department of Justice (2024).§ 1301.22 Exemption of agents and employees; affiliated practitioners..The text and limits of both exemptions: (b) covers agents and employees other than mid-level practitioners and permits administering or dispensing other than by issuance of prescription; (c) runs to a hospital or other institution and requires a designated internal code number appended to the institution's registration number, with a current list kept available for verification.. The second is the institutional exemption, the one the prescribing rule's list names 2Ref 2Drug Enforcement Administration, Department of Justice (2024).§ 1306.03 Persons entitled to issue prescriptions..That a controlled-substance prescription may be issued only by an individual practitioner both authorized to prescribe by the jurisdiction in which licensed and either registered or exempted under a closed list of two named sections, which does not include the agent and employee exemption..

The agent and employee exemption also carves out the class an NP sits in. It is written for an agent or employee of another registered practitioner who is not a mid-level practitioner, the category DEA's own regulations use for nurse practitioners and physician assistants. DEA's Practitioner's Manual restates the prescribing limit in a single line: this exemption does not extend to prescribing controlled substances 4Ref 4U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division (2023).Practitioner's Manual: An Informational Outline of the Controlled Substances Act.DEA's own plain-language restatement that the agent and employee exemption does not extend to prescribing controlled substances and does not reach a mid-level practitioner, and that an individual practitioner's registration rests on a state license..

The second exemption is the one people are half-remembering when they ask this question. It lets an individual practitioner administer, dispense or prescribe under a hospital's or other institution's registration, and it arrives with conditions: the institution authorizes the practitioner, designates a specific internal code number appended to the institution's own DEA registration number, and keeps a current list of those codes available for verification 3Ref 3Drug Enforcement Administration, Department of Justice (2024).§ 1301.22 Exemption of agents and employees; affiliated practitioners..The text and limits of both exemptions: (b) covers agents and employees other than mid-level practitioners and permits administering or dispensing other than by issuance of prescription; (c) runs to a hospital or other institution and requires a designated internal code number appended to the institution's registration number, with a current list kept available for verification.. A two-person practice with a collaboration agreement is not a hospital or institution, and no paperwork between the two of you creates the authority the section describes.

A pending Form 224 is not a temporary license

A pending application confers nothing at all. The regulation states that no person required to be registered may engage in any activity for which registration is required until the application is granted and the Certificate of Registration issued 5Ref 5Drug Enforcement Administration (Code of Federal Regulations, Title 21, Part 1301) (2024).§ 1301.13 Application for registration; time for application; expiration date; registration for independent activities; application forms, fees, contents and signature; coincident activities.The bar on engaging in a registration-requiring activity until the application is granted and the Certificate of Registration issued, the 28-to-39-month initial practitioner registration period, and the dispensing-activity fee row of $888 for a three-year registration period on Form 224 new and Form 224a renewal as of the April 1, 2024 revision.. There is no provisional status written into that section, no grace period, and no mechanism by which someone else's registration stands in for yours while the application is processed.

What the application buys, once granted, is a three-year cycle. The fee table row for the dispensing activity is the row a practitioner registers under. It pairs DEA Form 224 for a new registration with Form 224a for renewal, at $888 for a three-year registration period as of the April 1, 2024 edition of the regulations 5Ref 5Drug Enforcement Administration (Code of Federal Regulations, Title 21, Part 1301) (2024).§ 1301.13 Application for registration; time for application; expiration date; registration for independent activities; application forms, fees, contents and signature; coincident activities.The bar on engaging in a registration-requiring activity until the application is granted and the Certificate of Registration issued, the 28-to-39-month initial practitioner registration period, and the dispensing-activity fee row of $888 for a three-year registration period on Form 224 new and Form 224a renewal as of the April 1, 2024 revision.. DEA may set an initial period between 28 and 39 months, assigning the registration to one of twelve expiration groups spread across the year 5Ref 5Drug Enforcement Administration (Code of Federal Regulations, Title 21, Part 1301) (2024).§ 1301.13 Application for registration; time for application; expiration date; registration for independent activities; application forms, fees, contents and signature; coincident activities.The bar on engaging in a registration-requiring activity until the application is granted and the Certificate of Registration issued, the 28-to-39-month initial practitioner registration period, and the dispensing-activity fee row of $888 for a three-year registration period on Form 224 new and Form 224a renewal as of the April 1, 2024 revision.. That fee moves by rulemaking, so confirm the current figure before you budget it.

How long the grant takes is the part nobody publishes. DEA's registration page routes a new practitioner or mid-level practitioner application to an online form and offers a link for checking the status of a submitted application, and it names no processing time and no service target 6Ref 6Drug Enforcement Administration, Diversion Control Division (2026).Diversion Control Division | Registration.That a new practitioner or mid-level practitioner applies on DEA Form 224 with Form 224a for renewal, that applications are submitted online, that the page offers a status-check link for a submitted application, and that it names no processing time or service target.. Treat any number of weeks you have heard as somebody's anecdote, and build the schedule around the grant date rather than a predicted one.

What the prescription itself has to carry

A registration number, and it has to belong to the practitioner issuing the prescription. The regulation on manner of issuance requires a controlled-substance prescription to bear the full name and address of the patient, the drug name, strength, dosage form, quantity prescribed, directions for use, and the name, address and registration number of the practitioner 7Ref 7Drug Enforcement Administration, Department of Justice (2024).§ 1306.05 Manner of issuance of prescriptions..What a controlled-substance prescription must bear, including the name, address and registration number of the practitioner; the institutional substitute of the institution's number plus the assigned internal code; and the provision allowing a secretary or agent to prepare a prescription for a practitioner's signature with responsibility resting on the signing practitioner.. The form has one prescriber on it, and there is no field for a borrowed number.

The single place the rules contemplate a substitute number is the institutional one described above: a practitioner exempted under the hospital provision writes the institution's registration number with the assigned internal code in place of a personal number 7Ref 7Drug Enforcement Administration, Department of Justice (2024).§ 1306.05 Manner of issuance of prescriptions..What a controlled-substance prescription must bear, including the name, address and registration number of the practitioner; the institutional substitute of the institution's number plus the assigned internal code; and the provision allowing a secretary or agent to prepare a prescription for a practitioner's signature with responsibility resting on the signing practitioner.. For a private practice that is a closed door, because the substitute number only exists where an institution has issued the code.

One nearby provision does contemplate two people touching a single prescription. It is worth reading precisely, because it is the sentence most often stretched into cover for this arrangement. A prescription may be prepared by a secretary or agent for the signature of a practitioner, and the practitioner who signs carries the responsibility if it fails to conform to the law 7Ref 7Drug Enforcement Administration, Department of Justice (2024).§ 1306.05 Manner of issuance of prescriptions..What a controlled-substance prescription must bear, including the name, address and registration number of the practitioner; the institutional substitute of the institution's number plus the assigned internal code; and the provision allowing a secretary or agent to prepare a prescription for a practitioner's signature with responsibility resting on the signing practitioner.. The prescriber is the one whose number appears and whose signature lands. The agent is preparing paper.

Where federal registration ends and state authority begins

Federal registration and state prescriptive authority are two separate credentials, and the prescribing rule requires both at the same time: an individual practitioner has to be authorized to prescribe by the jurisdiction in which licensed, and separately be registered with DEA or exempted 2Ref 2Drug Enforcement Administration, Department of Justice (2024).§ 1306.03 Persons entitled to issue prescriptions..That a controlled-substance prescription may be issued only by an individual practitioner both authorized to prescribe by the jurisdiction in which licensed and either registered or exempted under a closed list of two named sections, which does not include the agent and employee exemption.. DEA's Practitioner's Manual describes an individual practitioner's registration as resting on that state license 4Ref 4U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division (2023).Practitioner's Manual: An Informational Outline of the Controlled Substances Act.DEA's own plain-language restatement that the agent and employee exemption does not extend to prescribing controlled substances and does not reach a mid-level practitioner, and that an individual practitioner's registration rests on a state license.. A collaboration agreement is evidence about the state half of that pair. It says nothing about the federal half.

Most of what a new collaborative practice negotiates lives on the state side of the line: the psychiatrist requirement for collaborators of a PMHNP (a psychiatric-mental health nurse practitioner), the scope of what an agreement may authorize, and the advertising rules that govern license number and supervised-by disclosures. The commercial terms between you and the physician sit there too, whether the collaborator is paid a flat fee or a percentage, and they change none of the federal analysis.

Every rule on this page is a controlled-substance rule. A DEA registration is a controlled-substance registration, and the sections cited here speak to nothing else; what governs the rest of what you write sits with your board and your state's prescriptive-authority statute.

What to do while the application is pending

File on the right form, then arrange the schedule around the grant. A new practitioner or mid-level practitioner registration is applied for on DEA Form 224, with Form 224a for renewal, and both are submitted online through DEA's Diversion Control Division registration page, which also carries the status-check link for an application already filed 5Ref 5Drug Enforcement Administration (Code of Federal Regulations, Title 21, Part 1301) (2024).§ 1301.13 Application for registration; time for application; expiration date; registration for independent activities; application forms, fees, contents and signature; coincident activities.The bar on engaging in a registration-requiring activity until the application is granted and the Certificate of Registration issued, the 28-to-39-month initial practitioner registration period, and the dispensing-activity fee row of $888 for a three-year registration period on Form 224 new and Form 224a renewal as of the April 1, 2024 revision.6Ref 6Drug Enforcement Administration, Diversion Control Division (2026).Diversion Control Division | Registration.That a new practitioner or mid-level practitioner applies on DEA Form 224 with Form 224a for renewal, that applications are submitted online, that the page offers a status-check link for a submitted application, and that it names no processing time or service target.. After that the work is sequencing rather than paperwork.

The controlled-substance portion of the panel waits, or the collaborating physician prescribes it as the prescriber in fact, from their own evaluation and under their own signature and number. Whether that fits your panel, your agreement and your schedule is a business judgment for the two of you to make, with counsel if the arrangement is unusual. Practices commonly treat the wait as a constraint on the controlled-substance side alone, and route the rest of the build around it.

Two neighboring questions get the same answer for the same reason. Billing under a collaborator's NPI puts a different identifier on a different document and carries its own federal rules; prescribing after a collaborator quits is this problem arriving without warning, mid-panel. Both turn on whose identifier is on the record and what that identifier asserts about who did the work.

In most practices a queue of downstream steps waits on the registration, so the setup order after DEA approval is worth writing down while you wait. The federal rule itself is short enough to read in an afternoon: 21 CFR 1301.13, 1301.22, 1306.03 and 1306.05, plus 21 U.S.C. 843.